Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Directorate Changes

22 Oct 2020 07:00

RNS Number : 8456C
Devro PLC
22 October 2020
 

22 October 2020

 

DEVRO PLC ("DEVRO" OR THE "COMPANY")

 

Directorate Changes

 

Devro, one of the world's leading manufacturers of collagen products for the food industry, announces the appointment of Chantal Cayuela to the Board as an independent non-executive director of the Company with effect from 1 January 2021. Chantal will also become a member of the Audit Committee, the Executive Remuneration Committee and the Nomination Committee from that date.

Chantal currently leads the R&D and Innovation team for Kellogg's European business, where she has been a Vice President since 2018. In a broad-ranging, international, career working with global food manufacturers, she has helped to shape their commercial strategies through product innovation. Her career includes a period of over sixteen years working in a variety of roles at Danone through which she developed considerable expertise in the successful delivery of customer-focused innovation. She subsequently spent seven years leading the Group Bel's research, innovation and development during which time her leadership of, and approach to, product innovation played a pivotal role in reinvigorating the brand, enabling the business to grow beyond its traditional core cheese markets. Chantal is a French national and she holds a doctorate in Biotechnology Chemical Engineering Sciences.

Devro also announces that Dr Paul Withers, non-executive director, will retire from the Board on 31 December 2020. Consequently, from 1 January 2021, Lesley Jackson will become the Company's Senior Independent Director.

Steve Good, Devro's Chairman, said:

"I am delighted to welcome Chantal to Devro's Board of Directors. She brings extensive experience of successful product innovation in international food manufacturing businesses and will add valuable skills and insights to support the development and execution of the Company's growth strategy.

"On behalf of the Board, I would also like to thank Paul for his invaluable service as a non-executive director since 2011 and, particularly in the last year as the Company's Senior Independent Director, for his flexibility and contribution to the initiative to refresh the composition of the Board, completed with Chantal's appointment. I wish him well for the future."

Nothing in connection with Chantal's appointment falls to be disclosed under LR 9.6.13.

 

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGAAUUPUGMG
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.